Cargando…
Effective reduction of post‐inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido‐thiazolyl‐resorcinol (Thiamidol)
OBJECTIVE: Post‐inflammatory hyperpigmentation (PIH) is a major cosmetic concern especially in individuals with darker skin complexion. Unfortunately, treatment with anti‐inflammatory ingredients alone does not prevent the development of hyperpigmented spots. Recently, isobutylamido‐thiazolyl‐resorc...
Autores principales: | Roggenkamp, Dennis, Dlova, Ncoza, Mann, Tobias, Batzer, Jan, Riedel, Julia, Kausch, Martina, Zoric, Ivica, Kolbe, Ludger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251899/ https://www.ncbi.nlm.nih.gov/pubmed/33559186 http://dx.doi.org/10.1111/ics.12694 |
Ejemplares similares
-
Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase
por: Mann, Tobias, et al.
Publicado: (2018) -
Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi‐centre approach consisting of a double‐blind, controlled, split‐face study and of an open‐label, real‐world study
por: Philipp‐Dormston, W. G., et al.
Publicado: (2020) -
Identification of tyrosinase inhibitors from traditional Chinese medicines for the management of hyperpigmentation
por: Tang, Hsin-Chieh, et al.
Publicado: (2015) -
Urolithin and Reduced Urolithin Derivatives as Potent Inhibitors of Tyrosinase and Melanogenesis: Importance of the 4-Substituted Resorcinol Moiety
por: Lee, Sanggwon, et al.
Publicado: (2021) -
Molecular docking study of nuciferine as a tyrosinase inhibitor and its therapeutic potential for hyperpigmentation
por: Veerichetty, Veerabhuvaneshwari, et al.
Publicado: (2023)